vs

Side-by-side financial comparison of GREAT SOUTHERN BANCORP, INC. (GSBC) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $56.4M, roughly 1.4× GREAT SOUTHERN BANCORP, INC.). GREAT SOUTHERN BANCORP, INC. runs the higher net margin — 28.9% vs 7.4%, a 21.5% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -0.2%). GREAT SOUTHERN BANCORP, INC. produced more free cash flow last quarter ($70.1M vs $9.7M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 4.5%).

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

GSBC vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.4× larger
VMD
$76.2M
$56.4M
GSBC
Growing faster (revenue YoY)
VMD
VMD
+25.7% gap
VMD
25.5%
-0.2%
GSBC
Higher net margin
GSBC
GSBC
21.5% more per $
GSBC
28.9%
7.4%
VMD
More free cash flow
GSBC
GSBC
$60.4M more FCF
GSBC
$70.1M
$9.7M
VMD
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
4.5%
GSBC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GSBC
GSBC
VMD
VMD
Revenue
$56.4M
$76.2M
Net Profit
$16.3M
$5.6M
Gross Margin
57.9%
Operating Margin
34.5%
11.0%
Net Margin
28.9%
7.4%
Revenue YoY
-0.2%
25.5%
Net Profit YoY
9.1%
30.7%
EPS (diluted)
$1.44
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GSBC
GSBC
VMD
VMD
Q4 25
$56.4M
$76.2M
Q3 25
$57.8M
$71.9M
Q2 25
$59.2M
$63.1M
Q1 25
$55.9M
$59.1M
Q4 24
$56.5M
$60.7M
Q3 24
$55.0M
$58.0M
Q2 24
$56.7M
$55.0M
Q1 24
$51.6M
$50.6M
Net Profit
GSBC
GSBC
VMD
VMD
Q4 25
$16.3M
$5.6M
Q3 25
$17.8M
$3.5M
Q2 25
$19.8M
$3.2M
Q1 25
$17.2M
$2.6M
Q4 24
$14.9M
$4.3M
Q3 24
$16.5M
$3.9M
Q2 24
$17.0M
$1.5M
Q1 24
$13.4M
$1.6M
Gross Margin
GSBC
GSBC
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
GSBC
GSBC
VMD
VMD
Q4 25
34.5%
11.0%
Q3 25
38.2%
7.8%
Q2 25
41.0%
8.1%
Q1 25
38.4%
6.5%
Q4 24
31.8%
10.6%
Q3 24
36.6%
9.7%
Q2 24
36.8%
6.6%
Q1 24
32.1%
4.4%
Net Margin
GSBC
GSBC
VMD
VMD
Q4 25
28.9%
7.4%
Q3 25
30.7%
4.9%
Q2 25
33.4%
5.0%
Q1 25
30.7%
4.4%
Q4 24
26.4%
7.1%
Q3 24
30.0%
6.7%
Q2 24
30.0%
2.7%
Q1 24
26.0%
3.2%
EPS (diluted)
GSBC
GSBC
VMD
VMD
Q4 25
$1.44
$0.14
Q3 25
$1.56
$0.09
Q2 25
$1.72
$0.08
Q1 25
$1.47
$0.06
Q4 24
$1.27
$0.10
Q3 24
$1.41
$0.10
Q2 24
$1.45
$0.04
Q1 24
$1.13
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GSBC
GSBC
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$189.6M
$13.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$636.1M
$141.5M
Total Assets
$5.6B
$199.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GSBC
GSBC
VMD
VMD
Q4 25
$189.6M
$13.5M
Q3 25
$196.2M
$11.1M
Q2 25
$245.9M
$20.0M
Q1 25
$217.2M
$10.2M
Q4 24
$195.8M
$17.5M
Q3 24
$208.4M
$11.3M
Q2 24
$186.5M
$8.8M
Q1 24
$171.4M
$7.3M
Stockholders' Equity
GSBC
GSBC
VMD
VMD
Q4 25
$636.1M
$141.5M
Q3 25
$632.9M
$133.6M
Q2 25
$622.4M
$139.7M
Q1 25
$613.3M
$134.8M
Q4 24
$599.6M
$131.4M
Q3 24
$612.1M
$125.0M
Q2 24
$568.8M
$119.4M
Q1 24
$565.2M
$116.3M
Total Assets
GSBC
GSBC
VMD
VMD
Q4 25
$5.6B
$199.2M
Q3 25
$5.7B
$202.4M
Q2 25
$5.9B
$184.6M
Q1 25
$6.0B
$178.1M
Q4 24
$6.0B
$177.1M
Q3 24
$6.0B
$169.5M
Q2 24
$6.0B
$163.9M
Q1 24
$5.8B
$154.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GSBC
GSBC
VMD
VMD
Operating Cash FlowLast quarter
$81.5M
$18.4M
Free Cash FlowOCF − Capex
$70.1M
$9.7M
FCF MarginFCF / Revenue
124.3%
12.7%
Capex IntensityCapex / Revenue
20.3%
11.5%
Cash ConversionOCF / Net Profit
5.01×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$121.9M
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GSBC
GSBC
VMD
VMD
Q4 25
$81.5M
$18.4M
Q3 25
$5.6M
$18.4M
Q2 25
$39.3M
$12.3M
Q1 25
$15.0M
$2.9M
Q4 24
$44.1M
$15.0M
Q3 24
$17.7M
$12.7M
Q2 24
$43.5M
$10.2M
Q1 24
$-26.9M
$1.2M
Free Cash Flow
GSBC
GSBC
VMD
VMD
Q4 25
$70.1M
$9.7M
Q3 25
$3.9M
$10.7M
Q2 25
$34.9M
$4.1M
Q1 25
$13.1M
$-12.6M
Q4 24
$39.1M
$3.2M
Q3 24
$16.5M
$1.7M
Q2 24
$42.0M
$1.2M
Q1 24
$-27.7M
$-4.8M
FCF Margin
GSBC
GSBC
VMD
VMD
Q4 25
124.3%
12.7%
Q3 25
6.7%
14.9%
Q2 25
59.0%
6.5%
Q1 25
23.4%
-21.4%
Q4 24
69.3%
5.2%
Q3 24
30.1%
3.0%
Q2 24
74.1%
2.3%
Q1 24
-53.7%
-9.5%
Capex Intensity
GSBC
GSBC
VMD
VMD
Q4 25
20.3%
11.5%
Q3 25
3.0%
10.6%
Q2 25
7.4%
12.9%
Q1 25
3.5%
26.2%
Q4 24
8.7%
19.5%
Q3 24
2.1%
19.0%
Q2 24
2.7%
16.3%
Q1 24
1.6%
11.9%
Cash Conversion
GSBC
GSBC
VMD
VMD
Q4 25
5.01×
3.27×
Q3 25
0.31×
5.23×
Q2 25
1.99×
3.88×
Q1 25
0.87×
1.09×
Q4 24
2.95×
3.47×
Q3 24
1.07×
3.29×
Q2 24
2.56×
6.94×
Q1 24
-2.01×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons